262 related articles for article (PubMed ID: 24757116)
21. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
22. MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
Upadhyay N; Suppa A; Piattella MC; Bologna M; Di Stasio F; Formica A; Tona F; Colosimo C; Berardelli A; Pantano P
J Neurol; 2016 Oct; 263(10):2022-31. PubMed ID: 27411806
[TBL] [Abstract][Full Text] [Related]
23. Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases.
Murphy MA; Friedman JH; Tetrud JW; Factor SA
J Clin Neurosci; 2005 Nov; 12(8):941-5. PubMed ID: 16289932
[TBL] [Abstract][Full Text] [Related]
24. Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Swallow DMA; Murchie P; Counsell CE
Mov Disord Clin Pract; 2024 May; 11(5):478-487. PubMed ID: 38369623
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy.
Tse NY; Chen Y; Irish M; Cordato NJ; Landin-Romero R; Hodges JR; Piguet O; Ahmed RM
Brain Commun; 2020; 2(2):fcaa194. PubMed ID: 33381758
[TBL] [Abstract][Full Text] [Related]
27. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
Rippon GA; Boeve BF; Parisi JE; Dickson DW; Ivnik RI; Jack CR; Hutton M; Baker M; Josephs KA; Knopman DS; Petersen RC
Neurocase; 2005 Jun; 11(3):204-11. PubMed ID: 16006341
[TBL] [Abstract][Full Text] [Related]
28. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
Borroni B; Alberici A; Agosti C; Cosseddu M; Padovani A
Int Psychogeriatr; 2009 Jun; 21(3):463-8. PubMed ID: 19323870
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
Bruns MB; Josephs KA
Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
[TBL] [Abstract][Full Text] [Related]
30. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
[TBL] [Abstract][Full Text] [Related]
31. Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome.
Jatale V; Tiwari A; Kumar M; Gupta R; Kumar N
Ann Indian Acad Neurol; 2023; 26(5):708-714. PubMed ID: 38022458
[TBL] [Abstract][Full Text] [Related]
32. Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.
Whitwell JL; Schwarz CG; Reid RI; Kantarci K; Jack CR; Josephs KA
Parkinsonism Relat Disord; 2014 May; 20(5):493-8. PubMed ID: 24656943
[TBL] [Abstract][Full Text] [Related]
33. Progressive supranuclear palsy.
Giagkou N; Höglinger GU; Stamelou M
Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
[TBL] [Abstract][Full Text] [Related]
34. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Fabbrini G; Fabbrini A; Suppa A
Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
[TBL] [Abstract][Full Text] [Related]
35. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.
Alster P; Madetko N; Migda B; Nieciecki M; Kutyłowski M; Królicki L; Friedman A
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885575
[TBL] [Abstract][Full Text] [Related]
36. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
[TBL] [Abstract][Full Text] [Related]
37. Language impairment in progressive supranuclear palsy and corticobasal syndrome.
Peterson KA; Patterson K; Rowe JB
J Neurol; 2021 Mar; 268(3):796-809. PubMed ID: 31321513
[TBL] [Abstract][Full Text] [Related]
38. Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study.
Madetko-Alster N; Alster P; Bartošová T; Klempíř J; Migda B; Przewodowska D; Migda A; Friedman A
Neurol Neurochir Pol; 2023; 57(2):177-182. PubMed ID: 36519660
[TBL] [Abstract][Full Text] [Related]
39. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
Lee YE; Williams DR; Anderson JF
J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
[TBL] [Abstract][Full Text] [Related]
40. The applause sign in frontotemporal lobar degeneration and related conditions.
Schönecker S; Hell F; Bötzel K; Wlasich E; Ackl N; Süßmair C; ; Otto M; Anderl-Straub S; Ludolph A; Kassubek J; Huppertz HJ; Diehl-Schmid J; Riedl L; Roßmeier C; Fassbender K; Lyros E; Kornhuber J; Oberstein TJ; Fliessbach K; Schneider A; Schroeter ML; Prudlo J; Lauer M; Jahn H; Levin J; Danek A
J Neurol; 2019 Feb; 266(2):330-338. PubMed ID: 30506397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
